ECMO Flashcards
Indications/Disease Processes indicated for VA ECMO
Acute MI with refractory cardiogenic shock
Failure to wean from CPB postcardiotomy (hypocontractility, graft failure, persistent pulmonary HTN
Acute myocarditis
Acute Massive Pulmonary Embolism
Other forms (eg, endocrine) of cardiogenic shock
For support during interventional cardiology
Preoperative support (post infarct VSD or papillary rupture)
Acutely decompensated cardiomyopathy
Inflow cannula size for adult ECPR/flows
Greater than 60-70 mL/kg/min or 5 LPM may be needed
3.5-4 LPM requires 15-17 Fr femoral cannula
VA ECMO and transpulmonary flow
The higher the ECMO Q the lower the RV filling.
The lower the RV filling the lower the transpulmonary flow
Decreased lung perfusion increases the rate of lung injury and infection
Central cannulation fully achieves CPB and worsens the transpulmonary Q
Usual Venous cannula size
18-28 Fr in adults
Usual arterial cannula size
16-20 Fr in adults
Optimum placement of femoral venous line
Mid right atrium, at the middle of the SVC-RA junction
Distal perfusion catheter size
6-8 Fr
Axillary artery cannulation for ECMO
8 mm vascular end to side graft following exposure of the vessel below the right clavicle.
The most significant side effect is hypoperfusion with 20% developing compartment syndrome of ipsilateral arm
Hypoperfusion/compartment syndrome in axillary artery cannulation for ECMO; causes and treatment
Causes can be arterial narrowing from atherosclerotic disease distal to the graft, or narrowed arteries due to type A dissection. Venous causes are from decreased limb drainage from bleeding, DVT, poor placement of venous cannula, and cardiac tamponade.
Treatment usually is decreasing Q ECMO and elevate the arm. If a DVT is suspected then the arterial flow site must be changed
Techniques of LV unloading during VA ECMO
Additional inotropic support to increase contractility
IABP
Impella
Main PA cannulation (retrograde transpulmonary decompression)
Most common ECMO complication
Major Bleeding, affects 30-42% of ECLS patients.
One of the most common sites is intracranial hemorrhage.
(?AKI occurs in 47-56% of patients)
Treatment includes blood products, protamine, and avoidance of acidosis and hypothermia
Anticoagulation Recommendation
ACT 180-220
aPTT 1.5-2.5 times the normal.